1FDA. Communication about an ongoing safety review of CellCept ( mycophenolate mofetil) and Myfortic ( mycophenolic acid) [ EB/OL]. 2008-04-16. updated 2008-06-20. http://www. fda. gov.
2Roche. Important changes in the CellCept (mycophenloate mofetil) prescribing information-reports of progressive muhifocal leukoencephalopathy (PML) in patients treated with CellCept [EB/OL]. 2008-06. http://www.fda. gov.
